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Abstract  
 
Background  
Repetitive functional task practise (RFTP) is a promising treatment to improve upper 
limb recovery following stroke. We report the findings of a study to determine the 
feasibility of a multi-centre randomised controlled trial to evaluate this intervention.  
 
Methods 
A pilot randomised controlled trial was conducted. Patients with new reduced upper 
limb function were recruited within 14 days of acute stroke from three stroke units in 
North East England. Participants were randomised to receive a four week upper limb 
RFTP therapy programme consisting of goal setting, independent activity practise, 
and twice weekly therapy reviews in addition to usual post stroke rehabilitation, or 
usual post stroke rehabilitation. The recruitment rate; adherence to the RFTP 
therapy programme; usual post stroke rehabilitation received; attrition rate; data 
quality; success of outcome assessor blinding; adverse events; and the views of 
study participants and therapists about the intervention were recorded.  
 
Results  
Fifty five eligible patients were identified, 4-6% of patients screened at each site. 
Twenty four patients participated in the pilot study. Two of the three study sites met 
the recruitment target of 1-2 participants per month. The median number of face to 
face therapy sessions received was 6 [IQR 3-8]. The median number of daily 
repetitions of activities recorded was 80 [IQR 39-80]. Data about usual post stroke 
rehabilitation were available for 18/24 (75%). Outcome data were available for 22/24 
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(92%) at one month and 20/24 (83%) at three months. Outcome assessors were 
unblinded to participant group allocation for 11/22 (50%) at one month and 6/20 
(30%) at three months. Four adverse events were considered serious as they 
resulted in hospitalisation. None were related to study treatment. Feedback from 
patients and local NHS therapists about the RFTP programme was mainly positive. 
 
Conclusions  
A multi-centre randomised controlled trial to evaluate an upper limb RFTP therapy 
programme provided early after stroke is feasible and acceptable to patients and 
therapists, but there are issues which needed to be addressed when designing a 
Phase III study. A Phase III study will need to monitor and report not only recruitment 
and attrition but also adherence to the intervention, usual post stroke rehabilitation 
received, and outcome assessor blinding. 
 
Trial registration  
ISRCTN 58527251 
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Feasibility study; Randomised controlled trial; Stroke; Upper limb rehabilitation; 
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Background 
Loss of arm function affects 69% of people who have a stroke [1]. Only 12% of 
stroke patients with initial upper limb motor impairment regain full function [2]. Stroke 
patients who are unable to use their arm may require long term support from their 
families or social services. Patients report that rehabilitation pays insufficient 
attention to arm recovery and they have identified optimising arm function as a 
research priority [3]. It is currently unclear how to maximise arm recovery after 
stroke. A systematic review of upper limb therapy interventions suggests that 
patients benefit most from exercise programmes in which functional tasks are 
directly practised, rather than interventions which are impairment focused, such as 
muscle strengthening [4]. 
 
Functional or task specific practice is underpinned by the movement science 
approach to stroke rehabilitation [5]. Repetitive functional task practice (RFTP) seeks 
to enhance motor learning by undertaking practice of functionally relevant tasks [6,7]. 
Other key components of RFTP include: intensity of practice; active cognitive 
involvement; and feedback on performance [5]. A Cochrane overview of systematic 
reviews found moderate quality evidence that arm function following a stroke can be 
improved by repetitive task training [8]. However, included studies were small, often 
did not describe the interventions in detail, and several had methodological 
weaknesses [9–20]. The authors highlighted the need for further high quality 
randomised controlled trials to strengthen this evidence [8].  
 
We aimed to establish the feasibility of a Phase III multi-centre randomised 
controlled trial designed to determine the clinical effectiveness of an upper limb 
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RFTP therapy programme for acute stroke patients. The objectives of the pilot study 
were to report: the recruitment rate; adherence to the upper limb RFTP therapy 
programme; the usual post stroke rehabilitation received by study participants; the 
attrition rate; data quality; the success of outcome assessor blinding; adverse 
events; and the views of study participants and therapists about the intervention.  
 
Methods 
Study design  
We conducted a multi-centre pilot randomised controlled trial to inform the design of 
a Phase III study to evaluate an upper limb RFTP therapy programme for acute 
stroke patients. The Medical Research Council (MRC) guidance was followed to 
develop and evaluate the intervention [21]. A flowchart of the study design is shown 
in Figure 1.  
 
Study setting 
Three NHS stroke units in North East England participated in the pilot study. All 
provided in-patient acute stroke care and rehabilitation on a stroke unit and had 
community therapy follow up services. They were typical of stroke services which 
would be invited to participate in a multi-centre study.  
 
Participants 
We aimed to recruit patients with a recent first-ever or recurrent stroke resulting in 
new reduced upper limb function. Inclusion criteria were: age ≥ 18 years; within 14 
days of stroke onset; new reduced upper limb function but with retained ability to lift 
the affected hand any distance off their lap; capable of undertaking the upper limb 
7 
 
RFTP therapy programme and adhering to the study protocol; able to provide 
informed consent to participate in the study; and home address within the community 
services catchment area of a participating study site. Exclusion criteria were: unable 
to follow the upper limb RFTP programme e.g. due to cognitive impairment or 
receptive aphasia; other significant upper limb impairment e.g. fixed contracture, 
frozen shoulder, severe arthritis, and upper limb pain that inhibited participation in 
the upper limb RFTP therapy programme; and a diagnosis likely to interfere with 
rehabilitation e.g. registered blind, receiving palliative care. As this was a pragmatic 
study, we did not use standardised scales to define any inclusion or exclusion 
criteria. Inclusion and exclusion criteria were based upon clinical opinion reflecting 
how patients would be identified to receive the upper limb RFTP programme in 
clinical practice. Screening was undertaken by National Health Service (NHS) 
research support staff at each site who were Good Clinical Practice (GCP) certified 
and trained by in study methods and procedures by the study physiotherapist (LB).  
 
Recruitment and consent  
Potentially eligible patients were approached by NHS research support staff who 
discussed the study with them and provided a study information sheet. After allowing 
sufficient time for this information to be considered, written consent was obtained 
from patients who wished to take part.  
 
Baseline assessment 
The following data were collected prior to randomisation by NHS research support 
staff: demographic data; time from stroke; first ever or recurrent stroke; stroke type 
(infarct or haemorrhage); stroke subtype (total anterior circulation stroke (TACS), 
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partial anterior circulation stroke (PACS), lacunar stroke (LACS), posterior circulation 
stroke (POCS)) [22]; stroke severity (National Institutes of Health Stroke Scale 
(NIHSS)) [23]; pre-stroke handicap (Oxford Handicap Scale (OHS)) [24]; hand 
dominance; arm function (Action Research Arm Test (ARAT)) [25], arm strength 
(Motricity Index) [26], and grip strength (dynamometer). 
 
Randomisation 
Participants were randomised within 14 days of acute stroke to receive the upper 
limb RFTP therapy programme (in addition to usual post stroke rehabilitation) or 
usual post stroke rehabilitation in a 1:1 allocation ratio. A central independent web 
based randomisation service hosted by Newcastle University Clinical Trials Unit was 
used. Participants were stratified according to study centre to ensure that 
intervention and control group participants were evenly distributed across study 
centres. 
 
Development of the upper limb RFTP therapy programme  
We reviewed the theoretical basis of RFTP and the structure and content of the 
upper limb RFTP therapy programmes which had been evaluated in previous 
research [9–17]. The upper limb RFTP therapy programme was then developed in 
collaboration with stroke physiotherapists and occupational therapists. Feedback 
was sought from clinicians, stroke patients and carers. The therapy programme was 
then refined before being tested in a clinical setting. Prior to undertaking the pilot 
randomised controlled trial, the study physiotherapist who developed the programme 
(LB) delivered the upper limb RFTP therapy programme to seven stroke patients in 
two of the participating stroke units. As this was provided in addition to usual post 
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stroke rehabilitation, she worked closely with participants’ local NHS therapists, ward 
teams and community teams to ensure that care was coordinated. Feedback from 
study participants and the experience gained by the study physiotherapist were used 
to further refine the upper limb RFTP therapy programme. The study physiotherapist 
developed and provided a face to face training programme with regular updates and 
a manual to enable local NHS therapists to deliver the programme in the pilot study.  
 
Intervention: the upper limb RFTP therapy programme  
The upper limb RFTP therapy programme was a four week programme of twice daily 
self-practised RFTP for patients with new reduced upper limb function early after 
stroke led by local NHS therapists (a physiotherapist or occupational therapist). The 
programme comprised of functional tasks, embedded in routine everyday activities 
completed on the ward or at home. This aimed to make the programme highly 
relevant to participants, promote ‘carry over’ into real life situations, and encourage 
self-practise.  
 
With the support of local NHS therapist, participants selected and practised 
functional tasks, termed recovery activities, which involved goal-focused upper limb 
movement sequences. Recovery activities related to categories identified from the 
most popular participant-selected goals in previous studies: washing, dressing and 
eating/drinking [27,28]. There was also an optional category which enabled 
participants to select an activity which was not listed under the other categories (e.g. 
using a mobile phone). Optional tasks offered choice and aimed to enhance 
participant motivation.  
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Participants were asked to practise each selected recovery activity independently for 
up to 20 times, twice per day, for four weeks. For participants who were unable to 
attempt a full task e.g. picking up a cup, recovery activities were divided into part 
tasks e.g. reaching towards the cup and practised in the same way as full tasks. The 
duration and intensity of the upper limb RFTP therapy programme was based upon 
the interventions used in previous RCTs of RFTP [9-17], the feasibility of delivering 
the intervention in the NHS, and feedback from stroke patients and carers in the 
development phase. 
 
At the start of the programme, the local NHS therapist performed a routine clinical 
assessment to determine the patient’s upper limb impairment and to identify other 
neurological deficits that may impact on upper limb function (e.g. inattention or 
cognitive deficit). The participant identified their two most important upper limb 
rehabilitation priorities and these were used to set two functional rehabilitation goals 
which were potentially achievable within the four week programme. The therapist 
and participant then selected two recovery activities from lists created for each 
category.  A wide range of recovery activities was available in each category and 
they were ordered into three levels of ability which were generated by considering 
sensori-motor demands (e.g. the amount of upper limb movement and coordination 
required) and the level of mental processing needed to complete the activity. The 
local NHS therapist demonstrated the chosen recovery activities and ensured that 
the participant was confident to practise them independently.  
 
Intervention group participants were given an individualised upper limb RFTP 
participant handbook. The handbook included guidance about undertaking their 
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chosen recovery activities, along with sections to log their twice daily practice and to 
provide feedback about the upper limb RFTP therapy programme. The participant 
handbook also included a section with advice and information concerning stroke 
recovery and care of their affected upper limb. The local NHS therapist 
demonstrated how to use the handbook and how to complete the activity log sheets 
and feedback sections.  
 
Participants were reviewed by the local NHS therapist twice per week. These 
sessions consisted of a clinical re-assessment of the participant’s affected upper 
limb impairment and review of progress towards their chosen functional goals. The 
goals and/or recovery activities were adjusted according to progress. If the 
participant had achieved a goal, a new goal was set and a new recovery activity was 
selected. If the participant found a goal or recovery activity too challenging, 
alternatives were chosen. If a participant regained normal upper limb function and 
achieved all of their upper limb rehabilitation goals before the end of the four week 
intervention period, they were discharged from the programme.  Otherwise, 
participants received a final therapy review at the end of the four week programme. 
The final review included a discussion about the participant’s future goals and advice 
about maintaining upper limb function.  
 
Control treatment 
As we wished to assess the effectiveness of the intervention in addition to current 
clinical practice, usual post stroke rehabilitation was chosen as the control treatment. 
Participants randomised to receive control treatment also received a study 
handbook, prepared by the study team, which contained advice and information 
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about stroke, rehabilitation and positioning of the arm and hand after stroke. The 
duration and content of routine physiotherapy and occupational therapy provided to 
intervention and control group participants for four weeks post randomisation were 
recorded by local NHS therapists on a structured proforma. We acknowledge that 
there is currently no standard approach to upper limb rehabilitation post stroke as 
rehabilitation is tailored to the needs of each individual and is dependent upon the 
availability of local resources [29]. The National Clinical Guideline for Stroke 
recommends a minimum 45 minutes of each appropriate therapy for five days per 
week [30].  
 
Outcome assessments 
Outcomes were assessed at one month (+/- three days) and three months (+/- five 
days) following randomisation, and undertaken by trained staff at each site.  These 
time points will be used in a Phase III study to look at the treatment effect at the end  
of the intervention period and to report the longer term effectiveness of the upper 
limb RFTP therapy programme. The following data were collected: arm function 
(Action Research Arm Test (ARAT)) [25]; grip strength (dynamometer); arm strength 
(Motricity Index) [26]; extended activities of daily living (Nottingham Extended 
Activities of Daily Living Index) [31].  
 
Blinding 
Due to the nature of the intervention, it was not possible to blind stroke patients or 
local NHS therapists to treatment allocation. Outcome assessments were performed 
by four staff intended to be blinded to treatment allocation. After each assessment, 
the assessor was asked to record whether they had become unblinded. We 
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attempted to blind stroke unit staff to treatment allocation by means of the study 
handbooks which were given to both control and intervention groups and were 
identical in external appearance. 
 
Adverse events 
The safety of the upper limb RFTP programme was evaluated by examining the 
occurrence of adverse events in accordance with National Research Ethics 
Committee (NRES) guidance for non CTIMP trials [32]. To collect adverse event 
data, participants were asked at each outcome assessment if they had any new 
medical problems. Participants were also asked specifically about upper limb pain 
and fatigue using visual analogue scales, and muscle tone in the upper limb was 
assessed by the Modified Ashworth Scale [33]. 
 
Feedback from intervention group participants and therapists 
Intervention group participants were asked to provide feedback about the upper limb 
RFTP therapy programme on their activity log sheets. They were also asked open 
questions about their experiences and opinions about the therapy programme at 
therapy reviews by local NHS therapists. The study therapist (LB) undertook semi-
structured 1:1 interviews with a convenience sample of patients when they 
left/completed the therapy programme and with the three main local NHS therapists 
who had delivered the upper limb RFTP programme. These data were coded and 
categorised into positive and negative comments and themes. 
 
Sample size and statistical analysis plan 
As this was a pilot study a formal sample size calculation was not performed.  
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We aimed to recruit 60 participants, based on 1-2 participants per month, from three 
study centres recruiting for one year. This is the level of recruitment expected per 
site for multi-centre stroke rehabilitation trials in the UK [34]. Analysis of pilot studies 
should be mainly descriptive [35, 36]. Numbers and percentages were used for 
categorical variables. Mean and standard deviation (SD) or median and interquartile 
range [IQR] were reported. As data are available from larger studies of upper limb 
interventions post stroke, which recruited participants from a similar patient 
population and used the same validated outcome measures, we did not seek to use 
data from the pilot study to inform the sample size calculation for a larger trial.  
 
Ethics and permissions 
The study was approved by the National Research Ethics Service (NRES) 
Committee North East - Newcastle & North Tyneside 2 (ref number 13/NE/0074). 
Local NHS research approvals were obtained for each of the study sites.  
 
Results  
The CONSORT Flow Diagram is shown in Figure 2. 
 
Screening and recruitment 
The planned recruitment period was one year but preparing study documents and 
seeking approvals took longer than anticipated. The actual recruitment period was 
03.06.13 – 28.02.14. Site A was open to recruitment for 30 weeks, site B 37 weeks, 
and site C 38 weeks. One thousand and seventy nine patients were screened and 
55 eligible patients were identified. This was between 4-6% of patients screened at 
each site.  
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The main recorded reason why patients were not eligible was that they had no new 
reduced upper limb function: 206/1,010 (20%). One hundred and eighty one patients 
(18%) were thought to be unable to comply with the upper limb RFTP programme 
because of speech or cognitive problems and 147 (15%) lived outside the catchment 
area for community follow up visits. The reason for exclusion was not recorded for 
337/1,010 (33%).  
 
Twenty four of the 55 (44%) eligible patients took part in the study. Site A recruited 
four participants, site B nine participants and site C 11 participants. There was a 
wide variation in the proportion of eligible patients recruited between sites. Site C 
recruited 11/11 (100%) eligible patients, site B recruited 9/23 (39%) and site A 4/21 
(19%). Potentially eligible patients did not participate because: 13 were already 
participating in another study which did not allow co-enrolment (site A); a local NHS 
therapist was not available to provide the RFTP programme to seven patients (four 
site A and three site B); NHS research support staff were not available to consent six 
patients (site B); and a consultant advised against approaching one patient (site B). 
Four patients (site B) declined to take part in the study: one felt that the upper limb 
RFTP therapy programme would be too difficult; one felt that there was insufficient 
content; and two did not give a reason. Two of the three study sites were able to 
recruit the target of 1-2 participants per month.  
 
Characteristics of the study population 
Table 1 shows the baseline characteristics of study participants. Participants were 
randomised a median of 5 [IQR 2-11] days after stroke and had reduced upper limb 
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function with a median ARAT of 20 [IQR 3-35]. As could be anticipated in a small 
pilot study, intervention and control groups were not well matched at baseline. 
Intervention group participants were older, had less severe strokes with milder upper 
limb impairment and function, and were randomised earlier than control group 
participants.  
 
Intervention  
Seven local NHS therapists (four physiotherapists and three occupational therapists) 
were trained to deliver the upper limb RFTP therapy programme. Of 13 intervention 
group participants, four received the intended eight face to face therapy sessions. 
Two were discharged early from the programme as per protocol as they had 
achieved all of their upper limb therapy goals and had regained full upper limb 
function. One participant did not wish to undertake recovery activities and was 
discharged from the therapy programme. Two participants (site A) were reported to 
have received the upper limb RFTP therapy programme but documents were not 
returned to the coordinating centre so it is unclear how many face to face sessions 
they received. A further three participants did not receive all eight sessions and the 
reasons for this are unclear (site A n=1, site C n=2). One patient did not receive any 
of the upper limb RFTP therapy programme as the local NHS therapist was not 
informed that the patient was participating in the study (site B). The median number 
of therapy sessions delivered per patient was 6 [IQR 3 – 8].  
 
Sixty five upper limb rehabilitation goals were selected. The goals related to: 
dressing n=18 (28%); washing n=17 (26%); eating/drinking n=17 (26%); 13 (20%) 
were in the optional category and related to activities such as writing, handling 
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money, kitchen activities and playing cards. Sixty (92%) goals were achieved during 
the study. Participants were asked to record the number of repetitions for each 
recovery activity. The intended maximum number per day was 80 (20 repetitions of 
two activities, twice per day). The median number undertaken daily was 80 [IQR 39-
80].  
 
Usual post stroke rehabilitation 
Information about usual post stroke rehabilitation was available for 17/24 (71%) 
participants. Data were available for a median of 8 [IQR 6-19.5] days per participant 
for intervention group participants and 5 [IQR 3.5-11.5] days for control participants. 
Unfortunately we did not record when participants were discharged from usual post 
stroke rehabilitation. The content of therapy sessions was recorded for 238 sessions 
for intervention group participants and 94 sessions for control group participants. The 
intervention group/control participant sessions comprised: mobility 100 (42%) vs 43 
(46%); upper limb RFTP 21 (9%) vs 8 (9%); other upper limb rehabilitation 53 (22%) 
vs 21 (22%); activities of daily living 37 (16%) vs 13 (14%); and other 27(11%) vs 9 
(10%). 
 
Attrition 
Follow up at one month was 22/24 (92%): one participant withdrew from the study 
and one outcome assessment was missed. Follow up at three months was 20/24 
(83%). Three participants could not be contacted and one was overlooked in error.  
 
Outcome measures 
Outcome measures at one and three months are shown in Table 2.  
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Table 2 Clinical outcomes at one and three months 
 
 
 
The median ARAT score at one month was 55 [IQR 38 – 57] for the intervention 
group and 46 [IQR 29-57] for the control group. At three months the median ARAT 
score for the intervention group was 57 [IQR 50-57] and control group 48 [35 – 57]. 
The maximum score achievable on the ARAT is 57. Levels of missing data were 
acceptable. 
 
 
 Intervention  
1 month  
n=13 
Control  
1 month 
n=11 
Intervention  
3 months  
n=13 
Control  
3 months  
n=11  
 
Arm function (ARAT) [25]      
Median [IQR] 
Missing 
      
 
55 [38 – 57] 
1 
 
 
 
 
46 [29 – 57] 
2 
 
 
 
57 [50 – 57] 
3 
 
 
 
48 [35 – 57] 
1 
 
Grip strength 
(Dynamometer)   
 
Median [IQR] kg  
Missing 
 
 
 
 
15 [8 – 20] 
3 
 
 
 
11 [5 – 26] 
1 
 
 
 
13 [5-21] 
4 
 
 
 
14 [4-28] 
1 
Arm strength (Motricity 
Index) [26] 
 
Median [IQR] 
Missing 
 
 
 
 
91 [76 – 99] 
1 
 
 
 
 
 
79 [55-91] 
1 
 
 
 
88 [65 -99] 
3 
 
 
 
88 [72 – 94] 
1 
 
Nottingham Extended 
Activities of Daily Living 
Scale [31]  
 
Median [IQR]  
Missing 
 
 
 
 
 
36 [10 – 54] 
5 
 
 
 
 
34 [25 – 46] 
2 
 
 
 
 
43 [9-60] 
3 
 
 
 
 
52 [32 – 58] 
 2 
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Blinding 
Outcome assessors reported that they were unblinded to participant group allocation 
for 11/22 (50%) at one month 6/20 (30%) at three months. The same assessor 
carried out one and three month assessments for 20/21 (95%) participants. Because 
of the large number of staff providing care at each stroke unit we did not try to 
measure the success of group concealment among stroke unit staff.  
 
Adverse events  
Four adverse events were considered serious as they resulted in hospitalisation: two 
falls, one episode of postural hypotension and one episode of gastritis. All were 
considered unrelated to the upper limb RFTP therapy programme. Seventeen 
adverse events were reported, 10 in the intervention group and seven in the control 
group. All adverse events were considered unrelated to the intervention.   
 
Participants were specifically asked about upper limb pain, fatigue and assessed for 
increased muscle tone in their affected arm. At one month 5/13 (38%) participants in 
the intervention group and 6/11 (55%) participants in the control group reported pain 
in the upper limb affected by stroke. At three months these corresponding data were 
5/13 (38%) in the intervention group and 5/11 (45%) in the control group. Nearly all 
patients reported some degree of fatigue at one and three months. At one month 
5/13 (38%) participants in the intervention group and 5/11 (45%) participants in the 
control group had increased upper limb tone. At three months these corresponding 
data were: 3/13 (23%) in the intervention group and 5/11 (45%) in the control group. 
 
Feedback from intervention group participants and therapists 
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During the four week upper limb RFTP therapy programme, participants recorded 
107 positive comments about the programme on their therapy log sheets and 39 
negative comments. Positive comments reported that the programme was enjoyable, 
challenging and motivating. Negative comments predominantly related to fatigue, 
although some participants found the programme too challenging. At twice weekly 
therapy reviews nine participants gave positive comments to their local NHS 
therapist about the upper limb RFTP therapy programme, reporting that they felt they 
were benefiting from the programme. Eight participants gave negative comments 
about the programme which again predominantly related to fatigue. One participant 
did not enjoy participating in the upper limb RFTP therapy programme and another 
felt that it aggravated a back problem. All of the seven participants who provided 
feedback at the end of the upper limb RFTP therapy programme to their NHS 
therapist felt that it was reasonable to start early after stroke. Six felt that being 
reviewed twice per week by the local NHS therapist was about right, and one felt that 
this was not enough. Six found the participant handbook helpful.  All found goal 
setting useful. Three participants took part in a 1:1 semi structured interview with the 
study physiotherapist upon completing the upper limb RFTP therapy programme. No 
points were raised that had not been identified previously.  
 
The three therapists who had the most experience of delivering the upper limb RFTP 
therapy programme participated in semi-structured interviews at the end of the study. 
They provided positive feedback about the upper limb RFTP programme and gave 
some suggestions about minor changes to study documents.  
 
Discussion   
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We have demonstrated that a multi-centre randomised controlled trial to determine 
the clinical effectiveness of the upper limb RFTP therapy programme is feasible but 
there are a number of issues which need to be addressed in the design and delivery 
of a Phase III study. 
 
NHS site selection will be an important issue. One of the strengths of the pilot study 
was that it was a multi-centre study undertaken in sites which are typical of sites 
which are likely to participate in a Phase III study. Pilot studies are often undertaken 
in a single centre where the chief investigator is based, with strong local ownership 
and engagement of clinical and research teams. This can lead to over-optimism 
about the feasibility of a multi-centre study.  
 
We have obtained valuable insight about issues which are likely to be encountered in 
a Phase III study and gained understanding about the type and amount of support 
which sites are likely to need from the study coordinating centre. Multi-centre stroke 
rehabilitation trials are relatively rare and two of the three sites had limited 
experience of stroke rehabilitation research. In selecting sites and throughout a 
Phase III study, we will need to ensure that key individuals within the stroke unit and 
community stroke teams are committed to the trial and are able to deliver the study 
as per protocol. It may be helpful to have several linked sites within a region which 
are supported by a local study coordinator.  
 
The recruitment target of 1-2 participants per month was met by two of the three 
study sites. It would not have been possible for sites to have more than two 
intervention participants at any one time because of the additional work load for local 
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NHS therapists. Funding for the upper limb RFTP programme was a NHS excess 
treatment cost [37]. The excess treatment cost was the cost of the upper limb RFTP 
programme over and above usual post stroke rehabilitation. Excess treatment costs 
are not research costs funded by a grant, but are costs funded by the normal NHS 
commissioning process for stroke rehabilitation services. Our experience of leading 
multi-centre stroke rehabilitation trials over the last ten years is that there is wide 
variation between NHS organisations in their approach to NHS excess treatment 
costs. Some NHS organisations provide additional funding to individual therapists or 
rehabilitation services to deliver study treatments, whilst others agree for study 
treatments to be undertaken within the current service budget. In this pilot study, the 
programme was delivered by local NHS therapists in addition to their usual work load 
and therapists did not always have dedicated time to provide the intervention and to 
complete study documents. In selecting sites for a Phase III study, we will need to 
consider their approach to excess treatment costs and the views of local therapists 
about delivering the upper limb RFTP programme within the local excess treatment 
costs policy. The approach of a NHS organisation to excess treatment costs may 
impact upon whether or not a site agrees to participate in the study, the delivery of 
the intervention, and data quality about the intervention and usual post stroke care.  
  
Although the recruitment target was met in two of the three sites, a large proportion 
of eligible patients were not enrolled (56%) and there was a wide variation between 
sites. A number of eligible patients were not approached at site A as they were 
participating in studies which did not allow co-enrolment. These were hyperacute 
and acute drug studies. Provided that there are no potential interactions between 
interventions, and assessments are not too burdensome, patients should be offered 
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the opportunity to participate in a second study. In selecting sites for a Phase III 
study we will need to determine the compatibility of our study with the site’s portfolio 
of research studies and discuss co-enrolment with the chief investigators of ongoing 
studies.  
 
Another reason for non-enrolment of potentially eligible patients relates to the lack of 
availability of NHS research support staff to recruit participants and local NHS 
therapists to deliver the upper limb RFTP therapy programme. Two sites had no 
prospective cover for absence. Although there was more than one NHS therapist 
trained to deliver the upper limb RFTP therapy programme at each site, when a 
member of the therapy team was away the time available for research activities was 
reduced, so patients could not be randomised. There was no ring fenced resource to 
provide study treatments, reflecting the reality of undertaking multi-centre 
rehabilitation studies within the NHS. The Phase III study design will need to allow 
for the impact holidays, sick leave, change of staff etc. upon recruitment and delivery 
of the intervention. 
 
Our eligibility criteria were pragmatic and based upon clinical judgement, as would 
be used to decide whether or not to provide the treatment in clinical practice. We 
may need to include arm function measured by the ARAT as an eligibility criterion for 
a Phase III study [25]. This measure of arm function is likely to be our primary 
outcome as it is well validated and is widely used in studies evaluating upper limb 
rehabilitation post stroke. The maximum ARAT score is 57 and the minimum 
clinically important difference is 6 points [38]. Because of a ceiling effect, we will 
need to consider excluding patients who score 52 or above at baseline so that we 
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will be able to detect this change at one and three months (three participants in the 
pilot study scored 52 or more at the baseline assessment). It would have been 
helpful to have assessed the inter-rater reliability of the ARAT and other key scales 
within the pilot study. This work will need to be undertaken during a Phase III study. 
 
Participants were willing to take part in the study within 14 days of acute stroke and 
felt that this was a reasonable time to be approached. Intervention and control 
groups were not well matched at baseline. This is likely to be due to a small sample 
size and should not be an issue in a larger study. As it is important that groups are 
balanced at baseline in terms of severity of upper limb function, participants will be 
stratified by this parameter at randomisation in a Phase III study.  
 
The intervention has been carefully developed with patient and carer involvement at 
all stages. Participants were able to practise recovery activities themselves as per 
protocol with twice weekly review by a therapists both in hospital and at home.  
The study manual and supporting documents can be used in a Phase III study and 
adhere to TIDieR (template for intervention description and replication) [39].   
 
There is wide variation in clinical practice regarding the amount and content of upper 
limb rehabilitation provided, so in a future study there is a need to accurately record 
the amount and content of the usual post stroke rehabilitation received by 
participants in both randomisation groups. As there were a number of non-returned 
or poorly completed therapy forms in the pilot study, methods of minimising this need 
to be included in a Phase III study. More information was available about the usual 
post stroke rehabilitation received by intervention group participants than those in the 
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control group, which could be a source of bias about the amount and content of 
therapy received. The forms used to record the amount and content of the 
intervention and usual post stroke rehabilitation will be reviewed by the study team 
and NHS therapists to see if they can be simplified and/or reduced. We need to 
develop a robust system of ensuring their return to the study coordinating centre, 
with regular checks for data completeness and data quality. Alternatively an 
electronic system could be developed to collect data with reminders and prompts but 
additional resource would likely be needed to support local data entry. We also need 
to stress in our training programme for local NHS therapists the importance of 
obtaining high quality data.  
 
The timing and content of outcome assessments will remain unchanged in a Phase 
III study. The attrition rate observed in the pilot study and completeness of key 
outcome measures are acceptable for a stroke rehabilitation study but could be 
improved. In a Phase III trial we will consider using electronic prompts and reminder 
letters for outcome assessors to try to prevent assessments being missed. We will 
review methods to try to prevent participants being lost to follow up by seeking 
information about discharge destination when a participant leaves hospital.  
 
Lack of blinding can result in numerous sources of bias. Particular risks for stroke 
rehabilitation trials are resentful demoralisation of participants randomised to the 
control group [40] and competitive therapy bias, where therapy staff may feel that 
patients in the control group are disadvantaged and subsequently provide them with 
increased rehabilitation [41]. We did consider developing an attention control 
treatment but this would have added to the complexity and cost of the trial. We were 
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disappointed that a large number assessments were unblinded at the one and three 
month outcome assessments. Unfortunately, we did not collect data about when and 
how outcome assessors became unblinded and in retrospect this would have been 
useful. All outcome assessors worked within the stroke unit and community stroke 
services at the site where they undertook assessments. For a Phase III study we will 
consider employing outcome assessors who work outwith the stroke service.  
 
The upper limb RFTP therapy programme was acceptable to patients early after 
stroke and local NHS therapists and the majority of goals were achieved. A number 
of patients in both intervention and control groups experienced fatigue. This is likely 
to be stroke related rather than specific to the intervention as there is a high 
prevalence of fatigue following stroke [42]. Fatigue needs to be taken into account 
when considering rehabilitation goals. During a Phase III study an Independent Data 
Monitoring and Ethics Committee (IDMEC) will monitor differences between 
intervention and control groups in levels of fatigue. No concerns about the safety of 
the upper limb RFTP programme were identified in the pilot study and the safety 
reporting system can be used in a multi-centre study. 
 
Conclusion 
A multi-centre randomised controlled trial to evaluate an upper limb RFTP therapy 
programme provided early after stroke is feasible and acceptable to patients and 
therapists, but there are issues which need to be addressed when designing a 
Phase III study. A Phase III study will the need to monitor and report not only 
recruitment and attrition but also adherence to the intervention, usual post stroke 
rehabilitation received, and outcome assessor blinding. Because of issues found in 
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the pilot study, a Phase III multi-centre study will require an internal pilot study with 
stop/go rules based upon recruitment rate, adherence to the intervention, attrition 
and completeness of outcome assessments. The internal pilot study will determine if 
the actions taken to address the issues raised in the current pilot study have been 
successful.  
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Table 1.  Baseline characteristics of participants 
 Intervention group 
n = 13 
Control group 
n = 11 
Gender  
Male n (%) 
Female n (%) 
 
 
8 (61.5%) 
5 (38.5%) 
 
 
9 (81.8%) 
2 (18.2%) 
 
Age  
Median [IQR] years 
Missing 
 
71 [67 – 78] 
2  
 
65 [57-72] 
1 
Pre-stroke handicap (Oxford Handicap Scale [24]) 
0 
1 
2 
3 
Range 0 – 5: no symptoms – severe handicap 
 
 
12 (92.3%) 
0 
1     (7.7%) 
0 
 
 
5 (45.5%) 
3 (27.3%) 
2 (18.2%) 
1   (9.1%) 
 
First ever stroke 
Missing 
8 (61.5%) 
0 
8 (72.7%) 
0 
Dominant hand affected by stroke 
Missing 
5 (38.5%) 
0 
7 (63.6%) 
0 
Time from stroke to randomisation  
 
Median [IQR] days 
Missing 
  
 
 
6 [2.5 -11.5] 
0 
  
 
 
4 [2 – 9] 
0 
  
Stroke type 
Assumed infarct (no clinically relevant infarct on CT) 
Clinically relevant infarct on CT/MRI 
Intracerebral haemorrhage 
Missing 
 
0 (0%) 
11 (85%) 
0   (0%) 
2 (15%) 
 
3 (27%) 
5 (46%) 
1   (9%) 
2 (18%) 
Stroke sub-type (n %) [22] 
Total anterior circulation syndrome (TACS) 
Partial anterior circulation syndrome (PACS) 
Lacunar stroke (LACS) 
Posterior Circulation Stroke (POCS) 
Missing 
 
1 (8%) 
2 (15%) 
8 (62%) 
0 (0%) 
2 (15%) 
 
1 (9%) 
5 (46%)  
4 (36%) 
1 (9%) 
0 (0%) 
Stroke severity (National Institutes of Health Stroke Scale [23]) 
Median [IQR)] 
Missing 
Range 0 – 42: no symptoms – severe impairment 
 
3 [2-5] 
1 
 
6 [3-7] 
0 
Arm function (Action Research Arm Test [25] ) 
Median [IQR] 
Missing 
Range 0 – 57: no movement – full function 
 
32 [10-37] 
 0 
 
8 [1-22] 
 0 
Arm strength (Motricity Index) [26]  
Median [IQR]  
Missing 
Range 0 – 100: no movement – normal strength 
 
 
 
73 [48-77] 
 2 
 
40 [29-52] 
 0 
Grip strength (dynamometer)  
Median [IQR] kg 
Missing 
  
 
12 [4- 21] 
2 
 
7 [2-18] 
0 
